Partner With Us NRI

Zenotech Laboratories Ltd share Price

Company details

6M Return 14.84%
1Y Return -2.14%
Mkt Cap.(Cr) 342.51
Volume 36,788
Div Yield 0.00%
OI Chg %
Volume 36,788

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Zenotech Laboratories Ltd Stocks COMPARISION


Equity Capital: 82.27 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 15,612.36 -19,132.24
LAST 3M 53,075.98 -4,241.70
LAST 6M 58,662.39 138,824.89
LAST 12M 133,944.68 162,473.45

Zenotech Laboratories Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Zenotech Laboratories Limited (Formerly Sunline Technologies Limited) was established in June, 1989. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company`s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. During financial year 2004-05, the Hon`ble High Court of Andhra Pradesh sanctioned the Scheme of Amalgamation with M/s. Zenotech Technologies Limited with effect from November 1st , 2003. The Company had issued 91,82,500 equity shares to erstwhile shareholders of M/s. Zenotech Laboratories Pvt. Ltd. and resultant, the name of Company was changed to "Zenotech Laboratories Ltd." with effect from August 10, 2004. M/s, Credence Pharmaceuticals Limited and M/s, Hemarus Healthcare Private Limited were merged with the Company, on May 2, 2006 through Scheme of Amalgamation, effective from October 1, 2005. 15 generic chemical oncology products were launched by the Company in India. Besides, the Company launched its anesthesia range of products during 2006. Consequent to the consummation of the merger of Ranbaxy Laboratories Limited into SPIL on March 24, 2015, SPIL indirectly acquired 46.84 percent of the voting rights held by Ranbaxy in, and control over the Company and became Promoter of the Company along with Daiichi Sankyo Company Limited and resultant, the Open Offer concluded in August 2015. The Company started production from its newly commissioned Depot Injectable facility in FY 2019-20. It renovated its Biotech API manufacturing facility and the same was leased to Sun Pharmaceutical Industries Limited, for their R&D activities effective from July, 2021.

Registered Address

S No 250-252 Turkapally Villag, Shameerpet Mandal RR District, Hyderabad, Telangana, 500078

Tel : 91-40-23480430/0435
Email : abdul.gafoor:zenotech.co.in
Website : http://www.zenotechlab.com

KFin Techologies Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 532039
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE486F01012

FAQ’s on Zenotech Laboratories Ltd Shares

You can buy Zenotech Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Zenotech Laboratories Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Oct 04, 2023 04:01 PM the closing price of Zenotech Laboratories Ltd was ₹ 56.12.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Oct 04, 2023 04:01 PM, the market cap of Zenotech Laboratories Ltd stood at ₹ 342.51.

The latest PE ratio of Zenotech Laboratories Ltd as of Oct 04, 2023 04:01 PM is 36.17

The latest PB ratio of Zenotech Laboratories Ltd as of Oct 04, 2023 04:01 PM is 0.25

The 52-week high of Zenotech Laboratories Ltd is ₹ 77.80 while the 52-week low is ₹ 45.00

Download Our App

market app
market app